HC Wainwright & Co. Maintains Buy on Affimed, Lowers Price Target to $5
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains a Buy rating on Affimed (NASDAQ:AFMD) but lowers the price target from $6 to $5.
June 05, 2023 | 1:53 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Affimed's price target has been lowered from $6 to $5 by HC Wainwright & Co., but the Buy rating is maintained.
The news of HC Wainwright & Co. maintaining a Buy rating on Affimed is positive for the stock. However, the lowering of the price target from $6 to $5 may create some uncertainty among investors. The overall impact on the stock price in the short term is expected to be neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100